IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma (Q34440364)
Jump to navigation
Jump to search
scientific article published on September 15, 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma |
scientific article published on September 15, 1997 |
Statements
1 reference
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma (English)
1 reference
D. G. Maloney
A. J. Grillo-López
C. A. White
D. Bodkin
R. J. Schilder
J. A. Neidhart
N. Janakiraman
K. A. Foon
T. M. Liles
B. K. Dallaire
K. Wey
I. Royston
1 September 1997
1 reference
15 September 1997
1 reference
90
1 reference
2188-2195
1 reference
Identifiers
1 reference